Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.39B |
| 2 |
Broadcom
AVGO
|
+$2.51B |
| 3 |
NVIDIA
NVDA
|
+$2.37B |
| 4 |
Microsoft
MSFT
|
+$1.65B |
| 5 |
Amazon
AMZN
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.02B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$776M |
| 3 |
UnitedHealth
UNH
|
+$737M |
| 4 |
MRSH
Marsh
MRSH
|
+$577M |
| 5 |
PepsiCo
PEP
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.17% |
| 2 | Financials | 12.48% |
| 3 | Consumer Discretionary | 11.87% |
| 4 | Healthcare | 11.61% |
| 5 | Communication Services | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Standard BioTools
LAB
$326M
| $15.5K | ﹤0.01% |
14,497
| – | – |
|
1777
Ubiquiti
UI
$31.8B
| $15.4K | ﹤0.01% |
53
| – | – |
|
1778
DT Midstream
DTM
$14.9B
| $15.2K | ﹤0.01% |
161
-16,465
| -99% | -$1.65M |
|
1779
Doximity
DOCS
$3.67B
| $14.9K | ﹤0.01% |
273
-11,383
| -98% | -$719K |
|
1780
Altimmune
ALT
$539M
| $14.6K | ﹤0.01% |
3,273
| – | – |
|
1781
Ituran Location and Control
ITRN
$1.08B
| $14.4K | ﹤0.01% |
+400
| New | +$14.4K |
|
1782
Petco
WOOF
$745M
| $14.1K | ﹤0.01% |
4,786
+294
| +7% | +$921 |
|
1783
Napco Security Technologies
NSSC
$1.28B
| $13.8K | ﹤0.01% |
601
+101
| +20% | +$2.86K |
|
|
VERV
1784
DELISTED
Verve Therapeutics
VERV
| $13.1K | ﹤0.01% |
3,398
-9
| -0.3% | -$60 |
|
1785
Boston Beer
SAM
$1.88B
| $12.9K | ﹤0.01% |
53
-2
| -4% | -$487 |
|
1786
Pacific Biosciences
PACB
$422M
| $12.8K | ﹤0.01% |
10,766
| – | – |
|
1787
UGI
UGI
$8B
| $12.2K | ﹤0.01% |
378
-60,220
| -99% | -$1.91M |
|
1788
RLI Corp
RLI
$5.68B
| $11.6K | ﹤0.01% |
144
| – | – |
|
1789
Recursion Pharmaceuticals
RXRX
$1.57B
| $11.5K | ﹤0.01% |
2,401
+128
| +6% | +$933 |
|
1790
Matador Resources
MTDR
$6.31B
| $11.4K | ﹤0.01% |
255
| – | – |
|
1791
iShares MSCI Europe Small-Cap ETF
IEUS
$175M
| $10.7K | ﹤0.01% |
188
| – | – |
|
1792
UWM Holdings
UWMC
$621M
| $10.3K | ﹤0.01% |
1,848
| – | – |
|
1793
EXL Service
EXLS
$4.23B
| $9.77K | ﹤0.01% |
212
+59
| +39% | +$2.84K |
|
1794
Vanguard S&P 500 Value ETF
VOOV
$6.58B
| $9.74K | ﹤0.01% |
55
| – | – |
|
1795
Liberty Broadband Class A
LBRDA
$4.14B
| $9.61K | ﹤0.01% |
115
| – | – |
|
1796
Lithia Motors
LAD
$7.78B
| $9.03K | ﹤0.01% |
32
+10
| +45% | +$3.4K |
|
1797
CNO Financial Group
CNO
$4.97B
| $9.02K | ﹤0.01% |
228
+45
| +25% | +$1.8K |
|
1798
Arcturus Therapeutics
ARCT
$157M
| $9.01K | ﹤0.01% |
950
-45
| -5% | -$714 |
|
1799
ONE Gas
OGS
$5.05B
| $8.78K | ﹤0.01% |
115
+32
| +39% | +$2.31K |
|
1800
AXIS Capital
AXS
$8.59B
| $8.61K | ﹤0.01% |
87
+21
| +32% | +$1.94K |
|
Similar funds
Amundi's Q1 2025 Portfolio in Review
As of Q1 2025, Amundi held 2,276 positions worth $275B, down 4.5% from $288B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Amundi deployed $14.6B of net new capital in Q1 2025, opening 139 new positions and adding to 822 existing holdings. Its largest new stake was APi Group: 474,780 shares worth $10.7M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Qualcomm, an estimated $1.02B trimmed.
- Amundi's largest Q1 2025 buy was APi Group: 474,780 shares worth $10.7M.
- Amundi added most to Apple in Q1 2025, an estimated $3.39B increase.
- Amundi's biggest Q1 2025 reduction was Qualcomm, cutting an estimated $1.02B.
- Amundi fully exited Arcadium Lithium plc in Q1 2025, selling an estimated $59.8M.
- Amundi's ten largest holdings make up 28% of its $275B portfolio in Q1 2025.
- Amundi opened 139 new positions and closed 84 in Q1 2025.
- Amundi's portfolio value fell 4.5% quarter-over-quarter to $275B.
Based on Amundi's 13F filing for Q1 2025, filed 15 May 2025.